Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.98
-0.01 (-0.10%)
At close: Mar 6, 2026, 4:00 PM EST
10.00
+0.02 (0.20%)
After-hours: Mar 6, 2026, 7:57 PM EST
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,180,125
Profits / Employee
$462,502
Market Cap
1.63B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Harmony Biosciences Holdings | 293 |
| Nuvation Bio | 291 |
| Innoviva | 159 |
| AnaptysBio | 104 |
| Nanobiotix | 103 |
NVAX News
- 5 days ago - Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 9 days ago - What's Going On With Novavax Stock On Friday? - Benzinga
- 9 days ago - Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof - Seeking Alpha
- 10 days ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 10 days ago - Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb - Benzinga
- 10 days ago - Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals - Reuters
- 10 days ago - Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - PRNewsWire